NHS proposals July 2017: have your say

Show sub-pages

Chronic liver disease consultation results and outcomes – you said, we did

During the summer of 2017, Bristol, North Somerset and South Gloucestershire CCGs consulted on a proposal to amend the chronic liver pathways to make it easier for patients to access the right treatment for themselves.

Following the consultation exercise, the combined Governing Body of Bristol, North Somerset and South Gloucestershire CCGs approved the new pathways and they will come into effect at the end of 2017.

As part of our consultation principles, we report back on what you said to us about the proposals and what our response was. A summary of this can be found in the ‘You Said, We Did’ report below.

Cover for NHS Proposals 2017 - Chronic Liver Disease: You Said, We Did Report

NHS Proposals 2017 - Chronic Liver Disease: You Said, We Did Report

This report summarises feedback we received during ourconsultation on chronic liver disease pathway, and what we have done as a result. 

About the proposal

Bristol, North Somerset and South Gloucestershire CCGs are proposing to ensure there is a consistent approach to testing for and treating chronic liver disease across Bristol, North Somerset and South Gloucestershire.

This would address current local variation in the identification, treatment and management of chronic liver disease in primary care.

A recent review found that abnormal liver function tests are often repeated and patients who could well be managed in the community are referred to hepatologists in hospital. In future, there would be two liver disease clinical pathways.* One would be for chronic liver disease and the other for non-alcoholic fatty liver disease (NAFLD). This would reduce inconvenience to patients of unnecessary hospital appointments and tests.

These revised pathways aim to reduce the amount of unnecessary tests and referrals and ensure that patients receive the best advice and care from the most appropriate professional.

*a systematic way of treating and managing diseases in the NHS. A clinical pathway outlines the way a patient should be cared for through the NHS system from first presentation, followed by testing and diagnosis and through to completion of treatment.

Jargon Buster

Criteria Based Access [CBA] – Where a CCG has published a policy setting out eligibility criteria. If clinicians are content that the patient meets the criteria, they may proceed to treat without seeking funding approval.

Prior Approval [PA] – Where a CCG has published a policy setting out eligibility criteria. Clinicians, where they feel patients meet the criteria, must seek funding approval from the commissioners prior to treating.

Individual Fund Request [IFR] – Where a CCG has published a policy stating that certain treatments are not routinely funded. Treatment will only be funded via agreement from commissioners in exceptional circumstances

Clinical pathway – A systematic way of treating and managing diseases in the NHS. A clinical pathway outlines the way a patient should be cared for through the NHS system from first presentation, followed by testing and diagnosis and through to completion of treatment.